This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2017-2021.
Company Filing History:
Years Active: 2017-2021
Title: John O'Loughlin: Innovator in Fibronectin Based Scaffold Proteins
Introduction
John O'Loughlin is a notable inventor based in Stow, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of fibronectin based scaffold proteins. With a total of 3 patents to his name, O'Loughlin's work has implications in various diagnostic, research, and therapeutic applications.
Latest Patents
O'Loughlin's latest patents focus on fibronectin based scaffold proteins that exhibit improved stability. The applications provide formulations of these proteins that are stable and can be utilized in various fields, including diagnostics and therapeutics. Additionally, the patents cover cells that incorporate these proteins, as well as polynucleotides that encode the proteins or their fragments, and vectors that contain such polynucleotides.
Career Highlights
O'Loughlin is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to advancements in biotechnology. His work is pivotal in enhancing the stability and application of fibronectin based scaffold proteins.
Collaborations
Some of O'Loughlin's notable coworkers include Ray Camphausen and Bernice Yeung. Their collaborative efforts contribute to the ongoing research and development in the field.
Conclusion
John O'Loughlin's innovative work in fibronectin based scaffold proteins showcases his commitment to advancing biotechnology. His patents reflect a significant contribution to the field, with potential applications that can benefit various sectors.